|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-4-3
|
|
pubmed:abstractText |
We used duration of hospitalization as a surrogate for cost and event-free survival as a measure of effectiveness to estimate the cost-effectiveness ratios of various treatment regimens on Children's Cancer Group trials for acute lymphoblastic leukemia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1916-25
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11283123-Adolescent,
pubmed-meshheading:11283123-Adult,
pubmed-meshheading:11283123-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11283123-Child,
pubmed-meshheading:11283123-Child, Preschool,
pubmed-meshheading:11283123-Clinical Trials as Topic,
pubmed-meshheading:11283123-Cost-Benefit Analysis,
pubmed-meshheading:11283123-Disease-Free Survival,
pubmed-meshheading:11283123-Drug Administration Schedule,
pubmed-meshheading:11283123-Health Care Costs,
pubmed-meshheading:11283123-Humans,
pubmed-meshheading:11283123-Length of Stay,
pubmed-meshheading:11283123-Outcome Assessment (Health Care),
pubmed-meshheading:11283123-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11283123-Recurrence
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
|
|
pubmed:affiliation |
Department of Pediatric Hematology-Oncology, Childrens Hospital, Los Angeles, CA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
